Skip to main content
  • Published:

Toxicity of Halogenated Oxyquinolines in Dogs. A Clinical Study

II. History, Symptoms, Laboratory Findings, Therapy, and Follow-Up

Toxiciteten av halogenerade oxikinoliner hos hund. En klinisk studie. II. Anamnes, symptombild, laboratorieundersökningar, terapi och uppföljning

Abstract

Intoxication due to short-term oxyquinoline therapy was studied in 100 dogs, which had been so treated because of diarrhoea (except in 2 cases). The latter condition was in itself mild and uncomplicated. The main symptoms of intoxication were listlessness or excitation and nervousness, aggressiveness, tremor, convulsions, and salivation. Clinical examination revealed myocarditis and liver injury. Mortality, i.e. the sum of spontaneous deaths and euthanasia, amounted to 30 %. The treatment considered to be most important was sedation and anticonvulsant measures. It was further essential to correct the dehydration, which was often present. A follow-up investigation showed that approx. 1/3 of the dogs which had recovered from the acute intoxication developed recurrent convulsions within the next 3 years.

Sammanfattning

Hundra fall av oxikinolinförgiftning hos hund har studerats. Behandling med oxikinoliner hade (utom i 2 fall) företagits på grund av att hundarna led av en lindrig, okomplicerad diarré. Symptomen utgjordes främst av slöhet eller exitation och nervositet, aggressivitet, muskelryckningar, kramper och salivation. Den kliniska undersökningen avslöjade myokardit och leverskada. Mortaliteten, summan av spontant döda och avlivade fall, var 30 %. Den viktigaste behandlingen är sedativ och antikonvulsiv terapi samt att korrigera den ofta föreliggande dehydreringen. En efterkontroll visar, att ungefär en tredjedel av de hundar som tillfrisknat från det akuta förgiftningstillståndet under de närmast 3 kommande åren får återkommande epileptiska anfall.

References

  • Arbeit, S. R., I. L. Rubin & H. Gross: Differential Diagnosis of the Electrocardiogram. F. A. Davis Co., Philadelphia 1960.

  • Bengtsson, K. & O. Vikrot: Retrograd amnesi efter broxikinolin. (Retrograde amnesia after broxyquinoline). Svenska Läk.-Tidn. 1972, 69, 14–16.

    Google Scholar 

  • Berggren, L. & O. Hansson: Treating acrodermatitis enteropathica. Lancet 1966, 1, 52.

  • Berggren, L., O. Hansson & I. Wahlberg: Läkemedelsbiverkan och tarmresorption av 8-hydroxykinolinpreparat. (Secondary effect and absorption from the intestine of 8-hydroxyquinoline drugs). Svenska Läk.-Tidn. 1968, 65, 3772–3773.

    Google Scholar 

  • Candlin, F. T.: The liver. In Canine Medicine. 1st Catcott Ed., Amer. vet. Publ., Inc., California 1968.

  • Crabo, B. & B. Lannek: Unpublished observation.

  • Detweiler, D. K., D. F. Patterson, H. Luginbühl, W. H. Rhodes, J. W. Buchanan, D. H. Knight & J. D. Hill: Diseases of the cardiovascular system. In Canine Medicine. 1st Catcott Ed., Amer. vet. Publ., Inc., California 1968.

  • Etheridge, J. E., Jr. & G. T. Stewart: Treating acrodermatitis enteropathica. Lancet 1966, 1, 261–262.

  • Ettinger, S. J. & P. F. Suter: Canine Cardiology, W. B. Saunders Co., Philadelphia 1970.

  • Griffith, R. W.: Intestopan, a 26-week oral toxicity study in dogs. Sandoz Ltd., Dept. Pharm. Tox., March 28, 1969 (unpublished).

  • Hangartner, P.: Troubles nerveux observés chez le chien après absorption d’Entéro-Vioforme Ciba. (Nervous symptoms observed in dogs after absorption of Enterovioform Ciba). Schweiz. Arch. Tierheilk. 1965, 107, 43–47.

    Google Scholar 

  • Hoerlein, B. F.: Canine Neurology. Diagnosis and Treatment. 2nd Ed., W. B. Saunders Co., Philadelphia 1971.

  • Kaeser, H. E. & G. Scollo-Lavizzari: Akute zerebrale Störungen nach hohen Dosen eines Oxychinolinderivates. (Acute cerebral disturbance after high doses of an oxyquinoline derivative). Dtsch. med. Wschr. 1970, 95, 394–397.

    CAS  Google Scholar 

  • Kaeser, H. E. & R. Wüthrich: Zur Frage der Neurotoxizität der Oxychinoline. (On the possible neurotoxicity of oxyquinoline). Dtsch. med. Wschr. 1970, 95, 1685–1688.

    Article  CAS  Google Scholar 

  • Kirk, R. W.: Current Veterinary Therapy. 4th Ed., W. B. Saunders Co., Philadelphia 1971.

  • Kjaersgaard, K.: Amnesia after clioquinol. Lancet 1971, 2, 1086.

  • Lannek, N.: A clinical and experimental study on the electrocardiogram in dogs. Thesis. Stockholm 1949.

  • Lannek, B.: Leverbiopsi hos hund. Ett diagnostiskt hjälpmedel. (Liver biopsy in dogs. A diagnostic aid). Svensk Vet.-Tidn. 1968, 21, 591–594.

    Google Scholar 

  • Lannek, B.: Toxicity of halogenated oxyquinolines in dogs. A clinical study. I. A survey of cases. Acta vet. scand. 1973, 14, 723–744.

    CAS  PubMed  Google Scholar 

  • Lannek, B. & L. Jönsson: Toxicity of halogenated oxyquinolines in dogs. A clinical study. V. Pathological findings. Acta vet. scand. 1974, 15, In press.

  • Lannek, B. & P. Lindberg: Vioform poisoning in dogs. The absorption of vioform from the intestine. Svensk Vet.-Tidn. 1972 a, 11, 438.

    Google Scholar 

  • Lannek, B. & P. Lindberg: Toxicity of halogenated oxyquinolines to dogs. The effect of feeding fouled herring. Acta vet. scand. 1972 b, 13, 441.

    Article  CAS  Google Scholar 

  • Lannek, B. & P. Lindberg: Toxicity of halogenated oxyquinolines in dogs. A clinical study. III. Intoxication experiments. Acta vet. scand. 1974 a, 15. In press.

  • Lannek, B. & P. Lindberg: Toxicity of halogenated oxyquinolines in dogs. A clinical study. IV. Tissue distribution and elimination in urine. Acta vet. scand. 1974 b, 15. In press.

  • Müller, L. F.: Die Mexaformvergiftung des Hundes (Klinische Demonstration). (The mexaform poisoning in the dog. Clinical demonstration). Kleintier-Prax. 1967, 12, 51–52.

    Google Scholar 

  • Paulsson, S. & B. Ã…berg: Kliniskt-kemiska och hematologiska normalvärden. (Clinical-chemical and hematological normal values in dogs). Svensk Vet.-Tidn. 1965, 15, 462–476.

    Google Scholar 

  • Püschner, H. & R. Fankhauser: Neuropathologische Befunde bei experimenteller Vioform-Vergiftung der weissen Maus. (Neurological symptoms after experimental Vioform poisoning in the white mouse). Schweiz. Arch. Tierheilk. 1969, 111, 371–379.

    Google Scholar 

  • Redding, R. W.: Diagnosis and therapy of seizures. J. Animal Hosp. Ass. 1969, 5, 79–92.

    Google Scholar 

  • Schantz, B. & B. Wikström: Suspected poisoning with oxyquinoline preparations in dogs. Svensk Vet.-Tidn. 1965, 4, 106–107.

    Google Scholar 

  • Strandvik, B. & R. Zetterström: Amaurosis after broxyquinoline. Lancet 1968, 1, 922–923.

  • Tateishi, J., S. Kuroda, A. Saito & S. Otsuki: Myelo-optic neuropathy induced by clioquinol in animals. Lancet 1971, 2, 1263–1264.

  • Wikström, B.: Neurologist undersökning av hund. (Neurological examination of dogs). Svensk Vet.-Tidn. 1969, 19, 587–596.

    Google Scholar 

  • Ã…berg, B. & B. Crabo: Kompendium i klinisk kemi. (Compendium of clinical chemistry. 3rd Ed.). Veterinärmedicinska föreningens kompendienämnd, Stockholm 1965.

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants from the Swedish Medical Research Council.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lannek, B. Toxicity of Halogenated Oxyquinolines in Dogs. A Clinical Study. Acta Vet Scand 15, 218–238 (1974). https://doi.org/10.1186/BF03547483

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1186/BF03547483

Keywords